These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26463985)

  • 21. Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery.
    Jothinath K; Balakrishnan S; Raju V; Menon S; Osborn J
    Ann Card Anaesth; 2021; 24(2):217-223. PubMed ID: 33884979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
    Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M
    Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan and gut mucosal blood flow--not all inotropes are created equal.
    Coopersmith CM
    Crit Care Med; 2005 Jan; 33(1):246-7. PubMed ID: 15644686
    [No Abstract]   [Full Text] [Related]  

  • 25. Levosimendan.
    Mason P
    Intensive Crit Care Nurs; 2003 Dec; 19(6):370-1. PubMed ID: 14637297
    [No Abstract]   [Full Text] [Related]  

  • 26. Levosimendan for low cardiac output: a pediatric experience.
    Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
    J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery.
    Mills KI; Costello JM; Almodovar MC
    Curr Vasc Pharmacol; 2016; 14(1):29-36. PubMed ID: 26463987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levosimendan in cardiac surgery: current best available evidence.
    Raja SG; Rayen BS
    Ann Thorac Surg; 2006 Apr; 81(4):1536-46. PubMed ID: 16564321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan for heart-operated patients: what is the state of the art?
    Tagarakis GI; Tsilimingas NB
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):22-4. PubMed ID: 19149702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
    Avila-Alvarez A; Del Cerro Marin MJ; Bautista-Hernandez V
    Curr Vasc Pharmacol; 2016; 14(1):37-47. PubMed ID: 26463986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levosimendan, a new inotropic and vasodilator agent.
    Toller WG; Stranz C
    Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs.
    Schwarte LA; Picker O; Bornstein SR; Fournell A; Scheeren TW
    Crit Care Med; 2005 Jan; 33(1):135-42; discussion 246-7. PubMed ID: 15644660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery.
    Al-Shawaf E; Ayed A; Vislocky I; Radomir B; Dehrab N; Tarazi R
    J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):353-7. PubMed ID: 16750735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial depression associated with pneumococcal septic shock reversed by levosimendan.
    Ramaswamykanive H; Bihari D; Solano TR
    Anaesth Intensive Care; 2007 Jun; 35(3):409-13. PubMed ID: 17591138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.
    Hasenfuss G; Pieske B; Castell M; Kretschmann B; Maier LS; Just H
    Circulation; 1998 Nov; 98(20):2141-7. PubMed ID: 9815868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Levosimendan--an alternative to conventional inotropic treatment of patients with acute heart failure?].
    Rasmussen T; Schmidt H
    Ugeskr Laeger; 2006 Jan; 168(3):261-5. PubMed ID: 16430807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
    Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
    Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing new drugs for heart failure in children.
    Wessel DL
    Pediatr Crit Care Med; 2006 Sep; 7(5):493-4. PubMed ID: 16960538
    [No Abstract]   [Full Text] [Related]  

  • 40. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.